Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of the American Medical Informatics Association : JAMIA|July 23, 2015
SMART on FHIR Genomics: facilitating standardized clinico-genomic appsGil Alterovitz, Jeremy Warner, Peijin Zhang, et al.
Journal of Oncology Practice|January 28, 2016
Implementing and Improving Automated Electronic Tumor Molecular ProfilingMatthew J Rioth, David B Staggs, Lauren Hackett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2004
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantationCorey Cutler, Haesook T Kim, Ephraim Hochberg, et al.
Abdominal Radiology (New York)|June 18, 2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patientsWendy Atkinson, Ciprian Catana, Jeremy S Abramson, et al.
Leukemia & Lymphoma|July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphomaEric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 13, 2021
Gender, Productivity, and Philanthropic Fundraising in Academic OncologySubha Perni, Danielle Bitterman, Jennifer Ryan, et al.
Blood Advances|September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphomaReem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Journal of Medical Internet Research|December 21, 2021
SMART COVID Navigator, a Clinical Decision Support Tool for COVID-19 Treatment: Design and Development StudyVarun Suraj, Catherine Del Vecchio Fitz, Laura B Kleiman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaRanjana H Advani, Daniel Lebovic, Andy Chen, et al.
Pageof 6